Associated Medical Conditions for Atherosclerosis

The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Percent Est Matches Bacteria in From Bacteria in To
Alzheimer's disease 32 % 16 50 524
Autism 38.2 % 42 110 524
Ulcerative colitis 39.8 % 43 108 524
Allergies 30 % 15 50 524
Schizophrenia 37.6 % 35 93 524
Mood Disorders 50 % 3 6 524
Ankylosing spondylitis 36 % 187 520 524
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 35.1 % 47 134 524
Rosacea 22.7 % 5 22 524
Psoriasis 47.8 % 22 46 524
Obesity 20.2 % 21 104 524
Multiple Sclerosis 37 % 37 100 524
Osteoporosis 50 % 11 22 524
neuropsychiatric disorders (PANDAS, PANS) 26.7 % 4 15 524
Obesity 40 % 22 55 524
ME/CFS without IBS 38.5 % 10 26 524
Multiple system atrophy (MSA) 28.6 % 6 21 524
Metabolic Syndrome 28.6 % 2 7 524
Amyotrophic lateral sclerosis (ALS) Motor Neuron 27.9 % 12 43 524
ME/CFS with IBS 47.4 % 9 19 524
Liver Cirrhosis 52.3 % 274 678 524
Parkinson's Disease 24.4 % 22 90 524
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 25 % 19 76 524
Chronic Kidney Disease 37.1 % 13 35 524
Systemic Lupus Erythematosus 34.8 % 23 66 524
Depression 28.4 % 23 81 524
Irritable Bowel Syndrome 43.5 % 27 62 524
IgA nephropathy (IgAN) 44.8 % 13 29 524
Insomnia 50 % 5 10 524
Hyperlipidemia (High Blood Fats) 12 % 3 25 524
hypertension (High Blood Pressure 33.3 % 2 6 524
hypercholesterolemia (High Cholesterol) 22.2 % 2 9 524
Allergic Rhinitis (Hay Fever) 27.8 % 10 36 524
gallstone disease (gsd) 60 % 9 15 524
Chronic Urticaria (Hives) 39.1 % 9 23 524
Histamine Issues 53.3 % 16 30 524
Graves' disease 25 % 2 8 524
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 37.5 % 9 24 524
Functional constipation / chronic idiopathic constipation 39 % 16 41 524
Epilepsy 36 % 9 25 524
Fibromyalgia 43.2 % 16 37 524
Inflammatory Bowel Disease 39.4 % 26 66 524
Type 1 Diabetes 32.7 % 17 52 524
COVID-19 27.8 % 10 36 524
Cerebral Palsy 70.6 % 12 17 524
Colorectal Cancer 31.1 % 92 296 524
Chronic Fatigue Syndrome 40 % 22 55 524
Celiac Disease 25.4 % 17 67 524
Coronary artery disease 12.5 % 2 16 524
Carcinoma 45.1 % 23 51 524
Barrett esophagus cancer 25 % 4 16 524
Bipolar Disorder 27.3 % 9 33 524
Asthma 44.4 % 12 27 524
Crohn's Disease 34 % 48 141 524
Acne 10.5 % 2 19 524
Generalized anxiety disorder 42.9 % 6 14 524
Small Intestinal Bacterial Overgrowth (SIBO) 50 % 8 16 524
Brain Trauma 45.5 % 10 22 524
Sjögren syndrome 46.3 % 19 41 524
Stress / posttraumatic stress disorder 32.1 % 18 56 524
Type 2 Diabetes 37.8 % 101 267 524
ADHD 17 % 8 47 524
Hashimoto's thyroiditis 57.1 % 8 14 524

(Legacy User)

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2021 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA